Tobacco Exposure Reprograms Lung Stem Cells Toward Specific Cancer Types

Johns Hopkins researchers found that chronic cigarette smoke exposure alters the epigenetic programming and gene expression of different lung stem cell populations, priming them for distinct forms of lung cancer. When cancer-associated mutations in KRAS and TP53 genes were introduced into the modified stem cells, they generated different cancer subtypes depending on which stem cell population was affected. The findings illuminate how environmental exposure, epigenetic changes, and genetic mutations cooperate in early-stage lung cancer development.

The research used three-dimensional laboratory models called organoids, which were cultivated from lung tissue and exposed to the chemical compounds found in cigarette smoke over an extended period. This approach allowed scientists to observe how different stem cell types within the lung responded to chronic smoke exposure at the molecular level, tracking shifts in how genes were activated or silenced without direct DNA sequence changes.

The study identified a critical distinction in how genetic mutations behave depending on which stem cell population carries them. When KRAS alterations appeared in one cell type, they produced adenocarcinomas, while the same TP53 loss in a different stem cell population generated squamous cell carcinomas. This suggests that environmental conditioning of stem cells creates the foundation upon which specific genetic mutations can act.